Learning Objectives:

      1.  Discussion of primary prevention of CAD

      2.  Discuss the role of Alirocumab and plaque regression

Session date: 
04/14/2023 - 7:30am to 8:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kevin Lee, MD